Home LiteratureArticle Details
PMID: 4723801 Published · ppublish English Journal Article

The bradykininase activities of extracts of dog lung.

British journal of pharmacology ·Vol. 47 ·No. 4 ·1973-04-00 ·Pages 799-807

Alabaster VA, Bakhle YS

Abstract

1. Homogenates of dog lungs freed from blood inactivate bradykinin. The bradykininase activity is present in soluble and particulate subcellular fractions.2. The fraction with the highest relative specific activity is that sedimenting between 8,700 g and 78,000 g. This fraction has been studied in more detail.3. There is evidence for two bradykinin inactivating enzymes in this fraction with apparent K(m) values of 7.5 muM and 120 muM.4. The bradykininase activity is not dependent on the concentration of chloride ion.5. The bradykininase activity is inhibited by EDTA, 2:3-dimercaptopropanol, nickel ions and some of the peptides from the venom of Bothrops jararaca and of Agkistrodon halys blomhoffii but not by 2-mercaptoethanol or N-ethylamaleimide.6. Angiotensin II in either 15 or 170 mM chloride ion is not an inhibitor of bradykininase activity but angiotensin I at either chloride concentration is an inhibitor. It is proposed that chloride is not necessary for binding of angiotensin I to converting enzyme but is necessary to ensure the correct orientation of substrate for hydrolysis to proceed.

MeSH Terms
Animals Bradykinin/analysis Chelating Agents/pharmacology Chlorides/metabolism Cobalt/pharmacology Dogs Ethylmaleimide/pharmacology Ileum/metabolism In Vitro Techniques Lung/enzymology Magnesium/pharmacology Manganese/pharmacology Mercaptoethanol/pharmacology Muscle, Smooth/enzymology,metabolism Peptide Hydrolases/metabolism Peptides/pharmacology Protease Inhibitors Zinc/pharmacology
Chemicals
Chelating Agents Chlorides Peptides Protease Inhibitors Cobalt Manganese Mercaptoethanol Peptide Hydrolases Magnesium Zinc Ethylmaleimide Bradykinin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Alabaster V A
Bakhle Y S
References (19)
19 references, click to expand
  1. Second kininase in human blood plasma.
    Nature. 1967 Sep 23;215(5108):1402-3 PMID: 6055465
  2. STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE.
    Br J Pharmacol Chemother. 1964 Apr;22:356-65 PMID: 14190470
  3. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.
    Nature. 1968 Nov 30;220(5170):919-21 PMID: 4301850
  4. Subcellular distribution and properties of the bradykinin inactivation system in rabbit brain homogenates.
    Biochem Pharmacol. 1969 Feb;18(2):548-9 PMID: 5778163
  5. Pharmacological significances of peptidase and proteinase in the brain. I. Enzymatic inactivation of bradykinin in rat brain.
    Biochem Pharmacol. 1969 Jan;18(1):119-28 PMID: 5780982
  6. Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme.
    Nature. 1970 Jan 24;225(5230):379-80 PMID: 4312128
  7. Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C.
    Biochemistry. 1971 Mar 16;10(6):972-80 PMID: 4323853
  8. Characteristics of the angiotensin I converting enzyme from dog lung.
    Nat New Biol. 1971 Feb 10;229(6):187-9 PMID: 4324574
  9. Carboxycathepsin--a key regulatory component of two physiological systems involved in regulation of blood pressure.
    Clin Chim Acta. 1971 Feb;31(2):413-9 PMID: 4324800
  10. Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines.
    Br J Pharmacol. 1971 Jun;42(2):305-7 PMID: 5091164
  11. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).
    J Pharmacol Exp Ther. 1971 Apr;177(1):291-300 PMID: 4327809
  12. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.
    Biochemistry. 1971 Oct 26;10(22):4033-9 PMID: 4334402
  13. Peptide inhibitors of pulmonary angiotensin I converting enzyme.
    Biochim Biophys Acta. 1971 Sep 22;242(3):662-7 PMID: 4334407
  14. The inactivation of bradykinin in the pulmonary circulation of isolated lungs.
    Br J Pharmacol. 1972 Jun;45(2):299-310 PMID: 4625922
  15. The existence of two forms of hypertensin.
    J Exp Med. 1954 Mar;99(3):275-82 PMID: 13130799
  16. Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma.
    Biochem Pharmacol. 1962 Dec;11:1123-8 PMID: 13944892
  17. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.
    Br J Pharmacol Chemother. 1967 Jun;30(2):417-24 PMID: 6036419
  18. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.
    Br J Pharmacol Chemother. 1965 Feb;24:163-9 PMID: 14302350
  19. Fate of angiotensin I in the circulation.
    Nature. 1968 Apr 13;218(5137):144-50 PMID: 4296306
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1973-04-00
Pages
799-807
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1776064
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com